Mahmut Kuntay KOKANALI, Salim ERKAYA, Meryem KURU PEKCAN, Demet KOKANALI, Yasemin TAŞÇI, A.Seval ERDİNÇ

Histerektomi ile Birlikte Yapılan Bilateral Salpingooferektomiye Bağlı Hipoöstrojenizmin Sistorektosel Gelişimine Etkisi

Amaç: Total abdominal histerektomi (TAH) ile birlikte uygulanan bilateralsalpingooferektomi (BSO) operasyonunun postoperatif iyatrojenik olarakgelişen hipoöstrojenemiye bağlı olarak sistosel ya da rektosel gelişimine etkisiolup olmadığını araştırmak.Yöntem: Bu retrospektif çalışmaya 1 Temmuz 2014 - 1 Temmuz 2015 tarihleriarasında prolapsus dışı benign nedenlerle TAH±BSO uygulanan hastalar dahiledildi. Hastalarla ilgili preoperatif veriler hastane kayıtlarından toplandı. Enaz postoperatif bir yılını tamamlayan, 50 tane TAH ve 50 tane TAH±BSOuygulanan hastalara ulaşıldı ve jinekolojik muayeneleri yapıldı.Bulgular: TAH grubundaki hastaların yaş ortalaması (48.08±2.23 yıl) vemenapoz sıklığı (44%) TAH±BSO grubundaki yaş ortalaması (51.46±3.78 yıl)ve menapoz varlığı (90%) değerlerine göre anlamlı derecede daha azdı.Gruplar arasında pre ve postoperatif sistosel ve rektosel dereceleribakımından istatistiki bir fark yoktu. Benzer şekilde her iki grup içinde pre vepostoperatif sistosel ve rektosel dereceleri açısından da anlamlı bir fark tesbitedilmedi. Ayrıca postoperatif gerek sistosel gerekse de rektosel derecesindeartışa neden olabilecek olası faktörlerin çoklu regresyon analizi sonucundahastalara ooferektomi uygulanmasının her iki durum için anlamlı birer faktörolarak tesbit edilmedi.Sonuç: TAH ile birlikte yapılan BSO operasyonu sonrası gelişenhipoöstrojenizm postoperatif kısa dönemde sistosel ve rektosel gelişimindeetkin bir faktör değildir.

Effect of Bilateral Salpingooferectomy due to Hypoestrogenism Combined with Hysterectomy on CystoRectocele Development

Aim: The objective of this study was to investigate the effect of total abdominal hysterectomy (TAH) combined with bilateral salpingooferectomy(BSO) due to hypoestrogenism on cystocele or rectocele development in postoperative period. Materials and Method: This retrospective study included patients who underwent TAH ± BSO for non-prolapse benign causes between 01 July 2014 and 01 July 2015. Preoperative data related to the patients were collected from hospital records. Patients who completed at least one postoperative year, 50 patients with TAH and 50 patients with TAH ± BSO were reached and gynecologic examinations were performed. Results: The mean age of the patients in the TAH group (48.08 ± 2.23 years) and the frequency of menopause (44%) were significantly lower than in the TAH ± BSO group (51.46 ± 3.78 years) and menopausal status (90%). There was no statistical difference between the groups in terms of pre- and postoperative cystocele and rectocele grades. Similarly, there was no significant difference between both groups in terms of pre- and postoperative cystocele and rectocele grades. In addition, multiple regression analysis of possible factors that may cause an increase in postoperative cystocele or rectoceles did not reveal a significant factor for either case of oophorectomy. Conclusion: Hipoestrogenism following the BSO operation with TAH is not an effective factor in the development of cystocele and rectocele in the postoperative short period.

PDF

___

Swift SE, Tate SB, Nicholas J. Correlation of symptoms with degree of pelvic organ support in a general population of women: what is pelvic organ prolapse? Am J Obstet Gynecol 2003;189:372–7.
Bradley CS, Nygaard IE. Vaginal wall descensus and pelvic floor symptoms in older women. Obstet Gynecol 2005;106:759–66.
Urogynecologic surgical mesh: update on the safety and effectiveness of transvaginal mesh placement for pelvic organ prolapse: US Food and Drug Administration. 2011. Available at: http://bit.ly/2oHG72C (accessed March 20, 2017).
C.M. Kim, M.J. Jeon, D.J. Chung, S.K. Kim, J.W. Kim, S.W.Bai. Risk factors for pelvic organ prolapse. International Journal of Gynecology and Obstetrics 2007; 98, 248-51.
Wingo, P.A., Huezo, C.M., Rubin, G.L., Ory, H.W., and Peterson, H.B. The mortality risk associated with hysterectomy. Am J Obstet Gynecol. 1985; 152: 803–8.
Carlson, K.J. Outcomes of hysterectomy. Clin Obstet Gynecol. 1997; 40: 939–46.
Kimberly A. Gerten, Alayne D. Markland, L. Keith Lloyd, and Holly E. Richter. Prolapse and Incontinence Surgery in the Older Woman. J Urol. 2008; 179: 2111–8.
Parker WH, Broder MS, Chang E, Feskanich D, Farquhar C, Liu Z, Shoupe D, Berek JS, Hankinson S, Manson JE. Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study. Obstet Gynecol. 2009;113:1027-37.
Baden WF, Walker T. Fundamentals, symptoms and classification. In: Baden WF, Walker T, eds. Surgical Repair of Vaginal Defects. Philadelphia, Pa.: Lippincott; 1992:14.
Bai SW, Chung DJ, Yoon JM, Shin JS, Kim SK, Park KH. Roles of estrogen receptor, progesterone receptor, p53 and p21 in pathogenesis of pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct. 2005;16:492-6.
J.H. Lang , L. Zhu , Z.J. Sun , J. Chen .Estrogen levels and estrogen receptors in patients with stress urinary incontinence and pelvic organ prolapse. International Journal of Gynecology and Obstetrics 2003; 80:35–9.
Eddie H.M. Sze, Gerry Hobbs. A prospective cohort study of pelvic support changes among nulliparous, multiparous, and pre- and postmenopausal women. European Journal of Obstetrics and Gynecology and Reproductive Biology 2012;160:232-5.
Bodner-Adler B, Bodner K, Schneidinger C, Kimberger O, Halpern K, Koelbl H, Umek W. Pelvic organ prolapse and endogenous circulating sex steroids in postmenopausal women: A case control-study. Eur J Obstet Gynecol Reprod Biol. 2017;210:177-181.
Denman MA, Gregory WT, Boyles SH, Smith V, Edwards SR, Clark AL. Reoperation 10 years after surgically managed pelvic organ prolapse and urinary incontinence. Am J Obstet Gynecol. 2008;198:555.e1-5.
Rortveit G, Subak LL, Thom DH, Creasman JM, Vittinghoff E, Van Den Eeden SK, Brown JS. Urinary incontinence, fecal incontinence and pelvic organ prolapse in a population-based, racially diverse cohort: prevalence and risk factors. Female Pelvic Med Reconstr Surg. 2010;16:278-83.
Jin L, Zhang XH, Wang JL, Yu YZ. Expression of estrogen receptor alpha and beta subtypes in the vaginal wall of women with anterior vaginal prolapse. Zhonghua Fu Chan Ke Za Zhi. 2007;42:18-21.
Ismail SI, Bain C, Hagen S. Oestrogens for treatment for prevention of pelvic organ prolapse in postmenopausal women. Cochrane Database Syst Rev 2010;9:CD007063.
Shveiky D, Kudish BI, Iglesia CB, Park AJ, Sokol AI, Lehman AM, Shara N, Howard BV. Effects of bilateral salpingo-oophorectomy at the time of hysterectomy on pelvic organ prolapse: results from the Women's Health Initiative trial. Menopause. 2015;22:483-8.